CSPIA
MIRA icon

Cary Street Partners Investment Advisory’s MIRA Pharmaceuticals MIRA Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$13K – 665
2024
Q3 		$13K Hold
10,000
– – ﹤0.01% 756
2024
Q2 		$6.37K Hold
10,000
– – ﹤0.01% 746
2024
Q1 		$11K Buy
+10,000
New +$10.9K ﹤0.01% 694

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Cary Street Partners Investment Advisory's MIRA Position: Q4 2024 in Review

Cary Street Partners Investment Advisory sold out of MIRA Pharmaceuticals (MIRA) in Q4 2024, closing a stake of 10,000 shares — an estimated $13K sold.

Cary Street Partners Investment Advisory first reported a position in MIRA in Q1 2024 and held it in 3 quarters. The position peaked at $13K in Q3 2024. 24 funds tracked by Wall St. Rank hold MIRA as of Q4 2024.

  • Cary Street Partners Investment Advisory reported no remaining MIRA Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 10,000 MIRA Pharmaceuticals shares in Q4 2024, an estimated $13K.
  • Cary Street Partners Investment Advisory first reported a position in MIRA Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Cary Street Partners Investment Advisory's MIRA Pharmaceuticals position peaked at $13K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2024.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2024, filed 14 Feb 2025.